August 2018

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive” or the “Company”), a specialty medical cannabis company, today announced that it has submitted an application to the U.S. Food and Drug Administration (“FDA”) seeking orphan drug designation of cannabidiol (“CBD”) for the treatment of hepatic ischemia and reperfusion injury (“IRI”) during liver […]

by

New research, published in the journal JAMA Psychiatry, shows that a dose of the cannabis extract cannabidiol improves brain function in people living with psychosis. A cannabis extract known as cannabidiol could be the ‘ideal treatment’ for psychosis. The new study was conducted by scientists at King’s College London (KCL) in the United Kingdom. It […]

by

A single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psychosis, research from King’s College London indicates. The finding, from a new randomized clinical trial, provides the first evidence of how cannabidiol acts in the brain to reduce psychotic symptoms. Cannabidiol, also referred to as CBD, is […]

by

Aug. 28 (UPI) — Researchers have developed a system that uses artificial intelligence to successfully detect diabetic retinopathy, according to a clinical trial in primary care offices. The trial compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults. The study, which […]

by

Aug. 28 (UPI) — Researchers have developed a system that uses artificial intelligence to successfully detect diabetic retinopathy, according to a clinical trial in primary care offices. The trial compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults. The study, which […]

by

Study findings showed that a single oral dose of cannabidiol modulated activation in parahippocampal, striatal and midbrain function, which are regions critical to the pathophysiology of psychosis. “We know from a couple of small-sized studies in patients with psychosis that cannabidiol has antipsychotic effects. However, how cannabidiol might work to treat psychosis (ie, its mechanisms) […]

by

Cannabis world domination.Sara Brittany Somerset As the marijuana business grows globally, many stock watchers and research analysts are making predictions about where the most significant investment opportunities are. Investment site The Motley Fool recently published an analysis by Keith Speights of forecasts for the 2022 marijuana market. A lot can happen even monthly in the ever-evolving […]

by

MMJ International has filed two applications with the U.S. Food and Drug Administration (FDA) requesting permission to begin clinical studies to test its pharmaceutical grade cannabis-based therapies in easing symptoms associated with Huntington’s disease and multiple sclerosis. MMJ also has requested a meeting with FDA officials to discuss the development process for an investigational new drug (IND). A pre-IND meeting helps create […]

by

TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Reviveâ€� or the “Companyâ€�), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, is pleased to provide a corporate update on its product strategy and business development activities in its objective in […]

by

MMJ International has filed two applications with the U.S. Food and Drug Administration (FDA) requesting permission to begin clinical studies testing its pharmaceutical grade cannabis-based therapies in easing symptoms associated with multiple sclerosis and Huntington’s disease. “The filing of these applications with the FDA brings us one step closer to helping persons suffering from these […]

by

TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Reviveâ€� or the “Companyâ€�), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, is pleased to provide a corporate update on its product strategy and business development activities in its objective in […]

by

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive” or the “Company”), a specialty medical cannabis company, today announced that it has submitted an application to the U.S. Food and Drug Administration (“FDA”) seeking orphan drug designation of cannabidiol (“CBD”) for the treatment of hepatic ischemia and reperfusion injury […]

by

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. DES MOINES – The Department of Public Health (IDPH) has received a number of questions about the legality of CBD […]

by

Warr Acres Mayor Jim Mickley in his office. (Photo by Emmy Verdin) OKLAHOMA CITY – Municipalities across Oklahoma are trying to determine whether they need to echo new state laws on medical marijuana or establish more conservative rules of their own. The City Council of Warr Acres, for example, recently passed an amendment to existing […]

by